These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 10217552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.
    Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ.
    Arch Gen Psychiatry; 2001 Aug; 58(8):755-61. PubMed ID: 11483141
    [Abstract] [Full Text] [Related]

  • 6. Contingency management for treatment of substance abuse.
    Stitzer M, Petry N.
    Annu Rev Clin Psychol; 2006 Aug; 2():411-34. PubMed ID: 17716077
    [Abstract] [Full Text] [Related]

  • 7. Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
    Roozen HG, Kerkhof AJ, van den Brink W.
    Eur Addict Res; 2003 Apr; 9(2):53-8. PubMed ID: 12644730
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Depot naltrexone: long-lasting antagonism of the effects of heroin in humans.
    Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW.
    Psychopharmacology (Berl); 2002 Feb; 159(4):351-60. PubMed ID: 11823887
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD.
    Am J Drug Alcohol Abuse; 2006 Feb; 32(4):503-17. PubMed ID: 17127538
    [Abstract] [Full Text] [Related]

  • 12. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone.
    Sullivan MA, Bisaga A, Glass A, Mishlen K, Pavlicova M, Carpenter KM, Mariani JJ, Levin FR, Nunes EV.
    Drug Alcohol Depend; 2015 Feb 01; 147():122-9. PubMed ID: 25555621
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Schedule of voucher delivery influences initiation of cocaine abstinence.
    Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ.
    J Consult Clin Psychol; 1998 Oct 01; 66(5):761-7. PubMed ID: 9803694
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder.
    Carroll KM, Nich C, Frankforter TL, Yip SW, Kiluk BD, DeVito EE, Sofuoglu M.
    Drug Alcohol Depend; 2018 Nov 01; 192():264-270. PubMed ID: 30300800
    [Abstract] [Full Text] [Related]

  • 18. Increasing opiate abstinence through voucher-based reinforcement therapy.
    Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, Umbricht-Schneiter A, Schuster CR, Preston KL.
    Drug Alcohol Depend; 1996 Jun 01; 41(2):157-65. PubMed ID: 8809505
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blame the counselling, not the implant. A response to Oliver, Horspool & Keen (2005).
    Kunøe N, Lobmaier P.
    Addiction; 2005 Jul 01; 100(7):1027-8; author reply 1028-9. PubMed ID: 15955020
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.